Literature DB >> 17628794

Manganese superoxide dismutase (Mn-SOD) gene polymorphisms in urolithiasis.

Volkan Tugcu1, Emin Ozbek, Bekir Aras, Serdar Arisan, Turhan Caskurlu, Ali Ihsan Tasci.   

Abstract

Polymorphism in manganese superoxide dismutase gene (Mn-SOD) is a new approach to identify its probable association with urolithiasis. Oxidative stress may be involved in the development of stone formation in the renal system. MnSOD is one of the primary enzymes that directly scavenges potential harmful oxidizing species. A valine (Val) to alanine (Ala) substitution at amino acid 16, occurring in the mitochondrial targeting sequence of the MnSOD gene, has been associated with an increase in urolithiasis risk. This study was conducted to investigate the association of MnSOD gene polymorphism with the risk of urolithiasis. We investigated the MnSOD in 66 stone-forming adults and 72 healthy volunteers. DNA was isolated from peripheral blood and genotyping was performed with PCR-based methods. Then PCR products were cut by BsaW1. Products were run on 3% agarose gel, 246 bp regions were 1-Ala-9, 164 and 82 bp products were determined as 2 Val-9. Chi-square test was used for comparison between patients and controls. In the control group the homozygote Ala allele was significantly higher than in the patient group (P < 0.01). The distribution of Ala/Val and homozygote Val alleles in the patient group was significantly higher than in the control group (P < 0.05). MnSOD genotype determination may provide a tool to identify individuals who are at risk of urolithiasis. This experiment also provides data about antioxidant status and stone formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628794     DOI: 10.1007/s00240-007-0103-7

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  25 in total

1.  Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk.

Authors:  L I Wang; D P Miller; Y Sai; G Liu; L Su; J C Wain; T J Lynch; D C Christiani
Journal:  J Natl Cancer Inst       Date:  2001-12-05       Impact factor: 13.506

2.  Cell injury associated calcium oxalate crystalluria.

Authors:  R L Hackett; P N Shevock; S R Khan
Journal:  J Urol       Date:  1990-12       Impact factor: 7.450

3.  Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis.

Authors:  Yasunori Itoh; Takahiro Yasui; Atsushi Okada; Keiichi Tozawa; Yutaro Hayashi; Kenjiro Kohri
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

Review 4.  Physicochemical aspects of urolithiasis.

Authors:  B Finlayson
Journal:  Kidney Int       Date:  1978-05       Impact factor: 10.612

5.  Calcium oxalate nephrolithiasis, a free or fixed particle disease.

Authors:  D J Kok; S R Khan
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

6.  Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease.

Authors:  S Shimoda-Matsubayashi; H Matsumine; T Kobayashi; Y Nakagawa-Hattori; Y Shimizu; Y Mizuno
Journal:  Biochem Biophys Res Commun       Date:  1996-09-13       Impact factor: 3.575

Review 7.  Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis.

Authors:  I Emerit
Journal:  Free Radic Biol Med       Date:  1994-01       Impact factor: 7.376

8.  The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism.

Authors:  ZhiJun Zhang; XiaoBin Zhang; Gang Hou; WeiWei Sha; Gavin P Reynolds
Journal:  J Psychiatr Res       Date:  2002 Sep-Oct       Impact factor: 4.791

9.  Oxalate toxicity in LLC-PK1 cells: role of free radicals.

Authors:  C Scheid; H Koul; W A Hill; J Luber-Narod; L Kennington; T Honeyman; J Jonassen; M Menon
Journal:  Kidney Int       Date:  1996-02       Impact factor: 10.612

Review 10.  Epidemiology of prostatitis.

Authors:  R O Roberts; S J Jacobsen
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

View more
  7 in total

1.  Contribution of human manganese superoxide dismutase tyrosine 34 to structure and catalysis.

Authors:  J Jefferson P Perry; Amy S Hearn; Diane E Cabelli; Harry S Nick; John A Tainer; David N Silverman
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

2.  Genetic polymorphism impact superoxide dismutase and glutathione peroxidase activity in charcoal workers.

Authors:  Kanika Miglani; Sunil Kumar; Anita Yadav; Neeraj Aggarwal; Ranjan Gupta
Journal:  Mol Biol Rep       Date:  2022-09-08       Impact factor: 2.742

Review 3.  The Molecular Aspect of Nephrolithiasis Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michal Bijak; Janusz Szemraj; Joanna Saluk-Bijak
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

4.  Association of calcium urolithiasis with urokinase P141L and 3'-UTR C>T polymorphisms in a Japanese population.

Authors:  Shoichi Hagikura; Kenji Wakai; Sayo Kawai; Yasuyuki Goto; Mariko Naito; Minako Hagikura; Momokazu Gotoh; Nobuyuki Hamajima
Journal:  Urolithiasis       Date:  2012-12-21       Impact factor: 3.436

5.  Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.

Authors:  Mohammad Reza Safarinejad; Nayyer Shafiei; Shiva Safarinejad
Journal:  Urolithiasis       Date:  2013-06-20       Impact factor: 3.436

6.  Genetic polymorphisms as prognostic factors for recurrent kidney stones: A systematic review and meta-analysis.

Authors:  Widi Atmoko; Putu Angga Risky Raharja; Ponco Birowo; Agus Rizal Ardy Hariandy Hamid; Akmal Taher; Nur Rasyid
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

7.  Superoxide Dismutase 1 and 2 Gene Polymorphism in Turkish Vitiligo Patients.

Authors:  Tuna A; Ozturk G; Gerceker Tb; Karaca E; Onay H; Guvenc Sm; Cogulu O
Journal:  Balkan J Med Genet       Date:  2017-12-29       Impact factor: 0.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.